Showing results (131-140 of 224) with videos related to
Sort By:
Pageof 23
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.BMC Nephrology|May 10, 2022
Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort studyCédric Jäger, Susanne Stampf, Karen Molyneux, et al.The Biochemical Journal|August 14, 2015
The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN diseaseGar Kay Hui, David W Wright, Owen L Vennard, et al.Lancet (London, England)|August 17, 2023
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialRichard Lafayette, Jens Kristensen, Andrew Stone, et al.Kidney International Reports|April 14, 2025
Systematic Scoping Review of Socioeconomic Burden and Associated Psychosocial Impact in Patients With Rare Kidney Diseases and Their CaregiversAnna Palagyi, Agnivo Sengupta, Monica Moorthy, et al.Kidney International Reports|May 14, 2023
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN StudyDana V Rizk, Brad H Rovin, Hong Zhang, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2022
Systemic Activation of Neutrophils by Immune Complexes Is Critical to IgA VasculitisSarah Mayer-Hain, Kathleen Gebhardt, Matthias Neufeld, et al.Kidney International Reports|January 16, 2026
Iptacopan in Patients With IgA Nephropathy From East AsiaHong Zhang, Vlado Perkovic, Jonathan Barratt, et al.Clinical Journal of the American Society of Nephrology : CJASN|April 13, 2023
Long-Term Outcomes in IgA NephropathyDavid Pitcher, Fiona Braddon, Bruce Hendry, et al.Kidney International|March 26, 2017
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working GroupHernán Trimarchi, Jonathan Barratt, Daniel C Cattran, et al.Pageof 23